アブストラクト | INTRODUCTION: The mortality risk after appendicectomy in patients with liver cirrhosis is predicted to be higher than in the general population given the associated risk of perioperative bleeding, infections and liver decompensation. This population-based cohort study aimed to determine the 90-day mortality risk following emergency appendicectomy in patients with cirrhosis. METHODS: Adult patients undergoing emergency appendicectomy in England between January 2001 and December 2018 were identified from two linked primary and secondary electronic healthcare databases, the clinical practice research datalink and hospital episode statistics data. Length of stay, re-admission, case fatality and the odds ratio of 90-day mortality were calculated for patients with and without cirrhosis, adjusting for age, sex and co-morbidity using logistic regression. RESULTS: A total of 40,353 patients underwent appendicectomy and of these 75 (0.19%) had cirrhosis. Patients with cirrhosis were more likely to be older (p < 0.0001) and have comorbidities (p < 0.0001). Proportionally, more patients with cirrhosis underwent an open appendicectomy (76%) compared with 64% of those without cirrhosis (p = 0.03). The 90-day case fatality rate was 6.67% in patients with cirrhosis compared with 0.56% in patients without cirrhosis. Patients with cirrhosis had longer hospital length of stay (4 (IQR 3-9) days versus 3 (IQR 2-4) days and higher readmission rates at 90 days (20% vs 11%, p = 0.019). Most importantly, their odds of death at 90 days were 3 times higher than patients without cirrhosis, adjusted odds ratio 3.75 (95% CI 1.35-10.49). CONCLUSION: Patients with cirrhosis have a threefold increased odds of 90-day mortality after emergency appendicectomy compared to those without cirrhosis. |
投稿者 | Adiamah, Alfred; Rashid, Adil; Crooks, Colin J; Hammond, John S; Jepsen, Peter; West, Joe; Humes, David J |
組織名 | National Institute for Health Research Nottingham Digestive Diseases Biomedical;Research Unit, Nottingham University Hospitals NHS Trust, E Floor West Block, QMC;Campus, Nottingham, NG7 2UH, UK. Alfie.adiamah@nottingham.ac.uk.;Campus, Nottingham, NG7 2UH, UK.;Division of Hepatobiliary and Transplant Surgery, Freeman Hospital, Freeman Rd,;High Heaton, Newcastle Upon Tyne, NE7 7DN, UK.;Department of Hepatology and Gastroenterology, Aarhus University Hospital,;Aarhus, Denmark.;Population and Lifesciences, School of Medicine, University of Nottingham,;Clinical Sciences Building, City Hospital, Nottingham, NG5 1PB, UK. |